The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter speciesPATERSON, David L.Clinical infectious diseases. 2006, Vol 43, issn 1058-4838, S43-S48, SUP2Article

Serious infections in the intensive care unit: Pseudomonas aeruginosa and acinetobacter baumanniiPATERSON, David L.Clinical infectious diseases. 2006, Vol 43, issn 1058-4838, 75 p., SUP2Serial Issue

Looking for risk factors for the acquisition of antibiotic resistance: A 21st-century approachPATERSON, David L.Clinical infectious diseases. 2002, Vol 34, Num 12, pp 1564-1567, issn 1058-4838Article

Serious infections caused by enteric gram-negative bacilli: Mechanisms of antibiotic resistance and implications for therapy of gram-negative sepsis in the transplanted patientPATERSON, David L.Seminars in respiratory infections. 2002, Vol 17, Num 4, pp 260-264, issn 0882-0546, 5 p.Article

Parenteral and inhaled colistin for treatment of ventilator-associated pneumoniaLINDEN, Peter K; PATERSON, David L.Clinical infectious diseases. 2006, Vol 43, issn 1058-4838, S89-S94, SUP2Article

Detection of plasmid-mediated class C β-lactamasesDOI, Yohei; PATERSON, David L.International journal of infectious diseases. 2007, Vol 11, Num 3, pp 191-197, issn 1201-9712, 7 p.Article

Aspergillus infections in transplant recipientsSINGH, Nina; PATERSON, David L.Clinical microbiology reviews (Print). 2005, Vol 18, Num 1, issn 0893-8512, 2, 44-69 [28 p.]Article

Setting and revising antibacterial susceptibility breakpointsTURNIDGE, John; PATERSON, David L.Clinical microbiology reviews (Print). 2007, Vol 20, Num 3, issn 0893-8512, 385, 391-408 [19 p.]Article

Strategies for Reduction in Duration of Antibiotic Use in Hospitalized PatientsHAYASHI, Yoshiro; PATERSON, David L.Clinical infectious diseases. 2011, Vol 52, Num 10, pp 1232-1240, issn 1058-4838, 9 p.Article

Has the Time Come for Routine Trimethoprim-Sulfamethoxazole Prophylaxis in Patients Taking Biologic Therapies?BODRO, Marta; PATERSON, David L.Clinical infectious diseases. 2013, Vol 56, Num 11, pp 1621-1628, issn 1058-4838, 8 p.Article

DoripenemPATERSON, David L; DEPESTEL, Daryl D.Clinical infectious diseases. 2009, Vol 49, Num 2, pp 291-298, issn 1058-4838, 8 p.Article

Acinetobacter baumannii : Emergence of a Successful PathogenPELEG, Anton Y; SEIFERT, Harald; PATERSON, David L et al.Clinical microbiology reviews (Print). 2008, Vol 21, Num 3, issn 0893-8512, 400, 538-582 [46 p.]Article

Impact of Antibiotic Resistance in Gram-Negative Bacilli on Empirical and Definitive Antibiotic TherapyPATERSON, David L.Clinical infectious diseases. 2008, Vol 47, issn 1058-4838, S14-S20, SUP1Article

Antibiotic regimens and intestinal colonization with antibiotic-resistant gram-negative bacilliDONSKEY, Curtis J.Clinical infectious diseases. 2006, Vol 43, issn 1058-4838, S62-S69, SUP2Article

Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosaRICE, Louis B.Clinical infectious diseases. 2006, Vol 43, issn 1058-4838, S100-S105, SUP2Article

Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter baumanniiPELEG, Anton Y; ADAMS, Jennifer; PATERSON, David L et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 6, pp 2065-2069, issn 0066-4804, 5 p.Article

Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter speciesRAHAL, James J.Clinical infectious diseases. 2006, Vol 43, issn 1058-4838, S95-S99, SUP2Article

Quantitative cultures for diagnosing ventilator-associated pneumonia : A critiqueFUJITANI, Shigeki; YU, Victor L.Clinical infectious diseases. 2006, Vol 43, issn 1058-4838, S106-S113, SUP2Article

Extended-spectrum β-lactamases : a clinical updatePATERSON, David L; BONOMO, Robert A.Clinical microbiology reviews (Print). 2005, Vol 18, Num 4, issn 0893-8512, 32 p., b-c, 657-686 [32 p.]Article

Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit?KOLLEF, Marin H.Clinical infectious diseases. 2006, Vol 43, issn 1058-4838, S82-S88, SUP2Article

Resistance in gram-negative bacteria : EnterobacteriaceaePATERSON, David L.American journal of infection control. 2006, Vol 34, Num 5, issn 0196-6553, S20-S28, SUP1Conference Paper

Systematic Review and Meta-Analysis of the Significance of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus IsolatesVAN HAL, Sebastiaan J; PATERSON, David L.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 1, pp 405-410, issn 0066-4804, 6 p.Article

Selective digestive tract decontamination- : Will it prevent infection with multidrug-resistant gram-negative pathogens but still be applicable in institutions where methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci are endemic?BONTEN, Marc J. M.Clinical infectious diseases. 2006, Vol 43, issn 1058-4838, S70-S74, SUP2Article

Collateral damage from cephalosporin or quinolone antibiotic therapyPATERSON, David L.Clinical infectious diseases. 2004, Vol 38, pp 341-345, issn 1058-4838, 5 p., SUP4Article

Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosaBONOMO, Robert A; SZABO, Dora.Clinical infectious diseases. 2006, Vol 43, issn 1058-4838, S49-S56, SUP2Article